Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.330
0.00 (0.00%)
May 13, 2025, 4:00 PM - Market open
Foghorn Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 61.03 | 55.45 | 80.34 | 52.21 | 101.14 | 92.8 | Upgrade
|
| Short-Term Investments | 159.56 | 188.29 | 153.72 | 293.58 | 53.15 | 92.98 | Upgrade
|
| Cash & Short-Term Investments | 220.59 | 243.75 | 234.06 | 345.8 | 154.29 | 185.77 | Upgrade
|
| Cash Growth | 6.74% | 4.14% | -32.31% | 124.12% | -16.95% | 1140.04% | Upgrade
|
| Receivables | - | - | - | - | 300 | - | Upgrade
|
| Prepaid Expenses | 4.83 | 5.85 | 6.12 | 5.6 | 5.27 | 4.92 | Upgrade
|
| Total Current Assets | 225.42 | 249.6 | 240.18 | 351.4 | 459.56 | 190.69 | Upgrade
|
| Property, Plant & Equipment | 31.54 | 32.61 | 42.91 | 49.4 | 56.08 | 62.33 | Upgrade
|
| Other Long-Term Assets | 1.73 | 1.78 | 2.82 | 4.09 | 4.13 | 2.58 | Upgrade
|
| Total Assets | 258.69 | 283.98 | 285.92 | 404.88 | 519.77 | 255.59 | Upgrade
|
| Accounts Payable | 4.07 | 3.79 | 6.26 | 5.41 | 3.82 | 3.68 | Upgrade
|
| Accrued Expenses | 6.45 | 8.53 | 8.43 | 11 | 9.56 | 6.78 | Upgrade
|
| Current Portion of Leases | 9.11 | 9.07 | 8.52 | 5.97 | 6.99 | 3.98 | Upgrade
|
| Current Income Taxes Payable | - | - | 0.67 | - | - | - | Upgrade
|
| Current Unearned Revenue | 51.67 | 45.61 | 34.55 | 32.82 | 28.32 | 2.02 | Upgrade
|
| Other Current Liabilities | - | - | - | - | - | 2.39 | Upgrade
|
| Total Current Liabilities | 71.31 | 66.99 | 58.44 | 55.21 | 48.69 | 18.85 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 19.65 | Upgrade
|
| Long-Term Leases | 25.74 | 28.06 | 36.56 | 45.54 | 51.34 | 58.36 | Upgrade
|
| Long-Term Unearned Revenue | 222.44 | 234.46 | 268.12 | 304 | 322.73 | 12.55 | Upgrade
|
| Other Long-Term Liabilities | 0.86 | - | - | 0.03 | 0.14 | - | Upgrade
|
| Total Liabilities | 320.34 | 329.51 | 363.11 | 404.77 | 422.9 | 109.41 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 515.35 | 512.52 | 395.2 | 377.23 | 361.13 | 309.13 | Upgrade
|
| Retained Earnings | -577.02 | -558.18 | -471.56 | -373.14 | -264.26 | -162.94 | Upgrade
|
| Comprehensive Income & Other | 0.01 | 0.14 | -0.83 | -3.99 | -0.01 | -0.01 | Upgrade
|
| Total Common Equity | -61.65 | -45.53 | -77.19 | 0.11 | 96.87 | 146.19 | Upgrade
|
| Shareholders' Equity | -61.65 | -45.53 | -77.19 | 0.11 | 96.87 | 146.19 | Upgrade
|
| Total Liabilities & Equity | 258.69 | 283.98 | 285.92 | 404.88 | 519.77 | 255.59 | Upgrade
|
| Total Debt | 34.85 | 37.13 | 45.07 | 51.51 | 58.33 | 82 | Upgrade
|
| Net Cash (Debt) | 185.74 | 206.62 | 188.98 | 294.29 | 95.96 | 103.77 | Upgrade
|
| Net Cash Growth | 13.47% | 9.33% | -35.78% | 206.69% | -7.53% | - | Upgrade
|
| Net Cash Per Share | 3.10 | 3.76 | 4.50 | 7.08 | 2.58 | 9.39 | Upgrade
|
| Filing Date Shares Outstanding | 55.72 | 55.61 | 42.57 | 41.8 | 41.42 | 36.82 | Upgrade
|
| Total Common Shares Outstanding | 55.72 | 55.59 | 42.28 | 41.8 | 41.3 | 36.79 | Upgrade
|
| Working Capital | 154.11 | 182.61 | 181.75 | 296.19 | 410.87 | 171.84 | Upgrade
|
| Book Value Per Share | -1.11 | -0.82 | -1.83 | 0.00 | 2.35 | 3.97 | Upgrade
|
| Tangible Book Value | -61.65 | -45.53 | -77.19 | 0.11 | 96.87 | 146.19 | Upgrade
|
| Tangible Book Value Per Share | -1.11 | -0.82 | -1.83 | 0.00 | 2.35 | 3.97 | Upgrade
|
| Machinery | - | 8.03 | 7.73 | 6.8 | 5.8 | 4.66 | Upgrade
|
| Leasehold Improvements | - | 17.02 | 17.24 | 17.12 | 17.06 | 16.96 | Upgrade
|
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.